Nerve conduction velocity in patients under longterm treatment with antiepileptic drugs by Krause, Klaus-Henning & Berlit, Peter
Electromyography and Clinical Neurophysiology 
Volume 30 
INDICES 1990 
Posterior antebrachial cutaneous neuropathy. Case report. CheinWei Chang and 
ShinJoong O h 3 
Electromyography of arrow release in archery. M P . Hennessy and A . W . Parker . . . . 7 
Comparison of the electrophysiological pattern of fatigue between athletes required to 
perform explosive and endurance sports. J.J. Vatine, A . Blank, M . Shochina, A . Swissa, 
Y . Mahler , B. Gonen and A . Magora 19 
Electromyographic findings in class I I division 2 and class H I malocclusions. G . A n t o n -
in i , L . Colantonio, N . Macret t i , G . L . Lenzi 27 
Ulnar-to-median anastomosis and its role in the diagnosis of lesions of the median nerve 
at the elbow and the wrist. V . Golovchinsky 31 
Somatosensory evoked potentials from median nerve; normative data. J. Verroust, 
A . Blinowska, R. V i l f r i t , D . Couperie, D . Malapert , M . Perrier 35 
Central motor conduction in ischaemic and hemorragic cerebral lesions. M . J . Segura, 
C . N . Gandolfo, R .E .P . Sica 41 
Electrotonic potentials of myelinated nerve fibers. A . Gydikov, A . Kossev, N . Traya-
nova and D . Stephanova 47 
Pseudoselectivity of the neuromuscular block in ocular myasthenia: a S F E M G study. 
B. Emeryk, K . Rowinska-Marcinska and T. Nowak-Michalska 53 
Nerve conduction velocity in patients under long term treatment with antiepileptic drugs. 
K . - H . Krause and P. Berlit 61 
Planar vector projection of short-latency median nerve somatosensory evoked potentials. 
G. Adler 67 
Diagnostic value of extensor digitorum brevis F-wave in L 5 root compression. I . Aiel lo , 
S. Patraskakis, G . F . Sau, G . Zi ra t tu , M . Bissakou, G. Patta and S. Traccis 73 
Visual and auditory evoked potentials in migraine. M . E . Drake, A . Pakalnis, S.A. Hiet-
ter and H . Padamadan 77 
Median frequency estimates of paraspinal muscles: reliability analysis. H . J . Biedermann, 
G. L . Shanks, J. Inglis 83 
Myobiofeedback in motor reeducation of wrist and fingers after hemispherial stroke. 
O. Rathkolb , St. Baykoushev and V . Baykousheva 89 
Effect of interelectrode recording distance on morphology of the antidromic sensory nerve 
action potentials at the finger. A.S. Wee and R .A. Ashley 93 
Electrophysiologic evaluation of beri-beri polyneuropathy. W . Djoenaidi and 
S .L.H. Notermans 97 
— — — —T 
Univers i ta ts-
Mixed and sensory nerve action potentials of the median nerve in patients with peripheral 
neuropathy or motor neurone disease. K . Nakashima and K . Takahashi 105 
Electromyographic analysis of reach in individuals with cerebral palsy. S.J. Spaulding, 
S.C. White, J.J. McPherson, R. Schild, C. Transon and P. Barsamian 109 
Quantitative sensory thresholds in carpal tunnel syndrome. M P . Merchut, M . A . Kelly 
and S. Cone Toleikis 119 
The long loop reflex in spinocerebellar degeneration and motor neuron disease — its 
changes with T R H therapy. T. Touge, H . Takeuchi, A . Yamada, H . M i k i and 
M . Nishioka 131 
The EMG-force relationships of skeletal muscle; dependence on contraction rate, 
and motor units control strategy. M . Solomonow, R. Baratta, H . Shoji and R. 
D 'Ambros ia 141 
Referral diagnosis versus electroneurophysiological finding. Two years electroneuromyo-
graphic consultation in a Rehabilitation Clinic. R. Danner 153 
The brainstem auditory evoked potential: effects of high frequency filtering. N . A . 
Shaw 159 
Relationship between the size of the recording electrodes and morphology of the 
compound muscle action potentials. A S . Wee and R .A. Ashley 165 
Height, an important factor in the latency of somatosensory evoked potentials. I I N . Sun-
woo, Hyo K . Cho and Shin J. Oh 169 
Segmental hypermobility in lumbar spine and entrapment of dorsal rami. Teuvo 
Sihvonen and Juhani Partanen 175 
Comparison of human triceps surae H-reflexes obtained from mid and distal recording 
sites. M . More l l i , S.J. Sullivan and D .E . Seaborne 181 
Secondary evoked muscle potential mapping according to the F , H , H F , F H features of 
nonexistence in proximal and distal limb muscles. A preliminary communication. A . 
Jusic, N . Fronjek, A . Bogunovic, L j . Sragalj, R. Baraba and S. Tomic 187 
The effects of stimulus rate on the brainstem auditory evoked potential. N . A . Shaw . . 195 
Reproducibility of somatosensory evoked potentials (SEPs) after median nerve stimula-
tion. T. Andersson and A . Persson 205 
On the parameterization of the E M G interference pattern power spectrum ( E M G -
I P - P S ) . I . Yaar and L . Niles 213 
A volume conductor study of electrotonic potentials of unmyelinated excitable fibers. 
A . A . Gydikov and N . A . Trayanova 227 
Electrophysiological and magnetic resonance imaging correlates of brainstem demyelinat-
ing lesions. A . Uncini , A . Faricelli, M . Assetta, A . Serio, A . Tartaro and D . Gambi 233 
Electromyographic findings in Emery-Dreifuss disease. K . Rowinska-Marcinska and 
I . Hausmanowa-Petrusewicz 239 
Muscle vibration facilitates orderly recruitment of motor units. C.-C. M a o , K . C. M c G i l l 
and L . J . Dorfmann 245 
Well preserved complex motor activities along with extreme electrophysiological pathol-
ogy in patients with M . Charcot-Marie-Tooth. Study of 10 cases. A . Jusic 253 
Post-contraction variations in motor pool excitability. B . R . Etnyre, T. Kinugasa and 
L . D . Abraham 259 
Electrophysiologic signs of sensory fiber lesion in spinal amyotrophies and the role of 
physiologic variations of sensory finger innervation pattern. A . Jusic, I . Bosnjak and 
Z . Hundozi 265 
Median nerve F wave conduction in healthy subjects over age sixty-five. C. Nelson, J. A . 
Whi te , R. U . Mitchell and C. D . Hal l 269 
Radiation-induced brachial plexopathy: clinical and electromyographical ( E M G ) 
considerations in 13 cases. P. Fardin, S. Le l l i , P. Negrin and S. Malu ta 277 
Surface E M G and motor unit activity of partially denervated human muscle during 
fatiguing submaximal isometric contraction. Ch. Giroux and B. M a t o n 283 
Aging and quantitative sensory thresholds. M . P . Merchut and S. Cone Toleikis 293 
Forearm Median Nerve Conduction Velocity in Carpal Tunnel Syndrome. W.S . Pease, 
H . H . Lee and E.W. Johnson 299 
Transmission of acoustic or vibratory signals from a contracting muscle to relatively 
distant tissues. A .S . Wee and R . A . Ashley 303 
Refractory studies in early detection of Carpal Tunnel Syndrome. S.K. Palliyath and 
L . Holden 307 
Technical approaches to hemisphere-selective transcranial magnetic brain stimulation. 
B . - U . Meyer, H . Kloten , T . C . Br i t ton and R. Benecke 311 
In Memoriam Prof. Dr. A. G Y D I K O V 323 
Volume-conducted or "far-field" compound action potentials originating from the 
intrinsic-hand muscles. A . S. Wee and R. A . Ashley 325 
Electromyographic reflexes evoked in human flexor carpi radialis by tendon vibration. 
F . W . J . Cody, C . N . Goodwin and H . C . Richardson 335 
Comparison of stretch reflex activities and reaction times in two separate age groups of 
human subjects. D . Sciarretta and P. Bawa 345 
Sensory nerve conduction study in forearm segment of superficial radial nerve: standard-
ization of technique. Chein Wei Chang and Shin Joong Oh 349 
Modulation of stretch activity with instruction. D . Sciarretta and P. Bawa 353 
Cryptogenic hemifacial spasm. A neurophysiological study. G . Roth , M . R . Magistris, 
P. Pinelli and B. Rilliet 361 
Determination of peak-ratio by digital turns-amplitude analysis on line. R. L iguor i , 
K . Dahl , S. Vingtoft and A . Fuglsang-Frederiksen 371 
Chronic inflammatory demyelinating polyneuropathy as first manifestation of human 
immunodeficiency virus infection. A . Cruz Martinez, J. Rabano, C. Villoslada and 
A . Cabello 379 
Do joint receptors modulate the motoneuron excitability? M A . Sabbahi, A . M . Fox 
and C. Druffle 387 
Comparisons between surface electrodes and intramuscular wire electrodes in isometric 
and dynamic conditions. B. Giroux and M . Lamontagne 397 
Observations of the posterior tibial nerve S E P of patients requiring extradural spinal 
surgery. A . N . Guthkelch, C R . Bamford, J .A. Gaines and R . B . Dzioba 407 
Quadriceps excitability is enhanced by a conditioning tap to the Achilles tendon. 
D . M . Koceja, G. Kamen and J.R. Burke 415 
Disintegration of the motor unit in post-polio syndrome. Part I . Electrophysiological 
findings in patients after poliomyelitis. B. Ryniewicz, K . Rowinska-Marcinska, 
B. Emeryk and I . Hausmanowa-Petrusewicz 423 
Electromyographic study of the sternocleidomastoid muscle in head movements. 
D . Costa, M . V i t t i and D . De Oliveira Tosello 429 
Double pattern of relationship between skin temperature, thermoregulation and sensory 
nerve conduction. J. Koczocik-Przedpelska and S. Gorski 435 
Conduction velocity along muscle fibers in situ in healthy infants. A. Cruz Martinez and 
J . M . Lopez Terradas 443 
Disintegration of the motor unit in post-polio syndrome. Part I I . Electrophysiological 
findings in patients with post-polio syndrome. B. Emeryk, K . Rowinska-Marcinska, 
B. Ryniewicz and I . Hausmanowa-Petrusewicz 451 
Discharge pattern of tonically activated motor units during unloading. L . Gerilovsky, 
A . Struppler, F. Velho and O. Niehage 459 
Unilateral enhancement of early and late blink reflex components in hemidystonia. 
R. Raffaele, A . Palmeri, G . Ricca, A. Casabona and V. Perciavalle 469 
Fiber density in congenital muscle fiber type disproportion. I . Congenital myopathies. 
K . Rowinska-Marcinska, M . H . Strugalska and I . Hausmanowa-Petrusewicz 475 
The behaviour of the mean power frequency of the surface electromyogram in biceps 
brachii with increasing force and during fatigue. With special regard to the electrode 
distance. B. Gerdle, N . - E . Eriksson and L . Brundin 483 
Magnetic stimulation F-responses. S. Gominak, D . Cros and B. Shahani 491 
Aging effects on brainstem auditory evoked potentials. P. Costa, P. Benna, C. Bianco, 
P. Ferrero and B. Bergamasco 495 
F-response assessment in healthy control subjects. B. Fierro, D . Raimondo and 
A. Modica 501 
Hereditary compression neuropathy. Report of a family. K . Van den Neucker and 
G . Vanderstraeten 509 
Tel . 32-10-86.67.37 
Nerve conduction velocity in patients 
under long term treatment with antiepileptic drugs 
K . - H . Krause and P. Beritt1 
Abstract 
Motor and sensory nerve conduction velocity (NCV) of median nerve and motor NCV of peroneal 
nerve were measured in 548 epileptic patients, aged 20 to 40 years, under long term treatment with 
antiepileptic drugs. Compared with a control collective of 70 healthy persons in the same age the 
epileptics showed a reduction of all NC Vs. 19 percent of the epileptic collective had at least 1 
diminished NCV. Negative correlations with total amount and average daily dose of antiepileptic drugs 
were found in both sexes for sensory NCV of median nerve and motor NCV of peroneal nerve, only in 
males also for motor NCV of median nerve. 
Only in females, duration of therapy correlated negative with sensory NCV of median and motor 
NCV of peroneal nerve. In patients under monotherapy the group with carbamazepine treatment showed 
the lowest NCV values, the difference being significant for motor NCV of median nerve in comparison 
to phenytoin and valproate sodium. It is concluded, that NCV generally is lowered under long term 
treatment with antiepileptic drugs and that phenytoin has no specific influence compared with the other 
drugs. 
Introduction 
A negative influence of phenytoin on the 
function of peripheral nerves has been dis-
cussed already in 1942 (10). Meanwhile a rever-
sible lowering of nerve conduction velocity 
(NCV) has been prooven in cases with acute 
phenytoin intoxication (1, 13, 18, 21). Concern-
ing the possible implication of long term treat-
ment the discussion is controverse: studies 
showed different results, the frequency of elec-
trophysiological abnormalities ranging from 
0% to 89% (2, 5-9, 11, 16, 22, 24-26). Ramirez 
et al. described a reversible neuropathy after 30 
years of phenytoin administration, character-
ized by axonal shrinkage and secondary demye-
lination in sural nerve biopsy (19). The aim of 
our study was: 1. to compare NCV's of a big 
number of patients, treated for a long time with 
Department of Neurology. University of Heidelberg, F.R.G. 
several antiepileptic drugs, with those of a 
control collective, 2. to evaluate possible rela-
tions of NCV's with total amount and daily 
dose of anticonvulsants as well as with the 
duration of treatment, and 3. to compare the 
patients under monotherapy with respect to 
possible differences in NCV's. 
Materials and methods 
548 epileptics (313 males, 235 females) of 
the Heidelberg outpatient clinic for convulsive 
disorders were investigated, who took antiepi-
leptic drugs since 1 year at least. To keep out 
influences of age, well-known for NCV's, only 
patients with an age of 20 to 40 years were 
considered. A further criterion for exclusion 
was the presence of a possible other cause of 
for neuropathy like diabetes mellitus, uremia or 
alcohol abuse. For each anticonvulsant drug 
taken by the patient, duration of therapy and 
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average daily dose were fixed. The whole dose 
and the average daily dose of all anticonvul-
sants were expressed as equivalent units, 1 unit 
equalling 50 mg phenytoin, 30 mg phenobarbi-
tal, 125 mg primidone, 50 mg CHP-phenobarbi-
tal, 200 mg carbamazepine, 50 mg mepheny-
toin, 250 mg ethosuximide, 300 mg valproate 
sodium, 2 mg clonazepam, 300 mg mesuximide, 
100 mg sultiam, or 250 mg trimethadione. 
NCV's were compared by Wilcoxon test with 
the values of 70 healthy controls of the same 
age group. Motor conduction velocity (MCV) 
of median and peroneal nerve was measured 
with a DISA 1500 E M G system using surface 
stimulating and recording electrodes, sensory 
conduction velocity (SCV) of median nerve on 
the forearm in antidromic technique using ring 
electrodes on the second digit. Skin temperature 
was constant at 34 °C by use of an automatic 
DISA skin temperature system. 
Results 
The epileptics had lower mean values of 
NCV's compared with the controls (table 1). 69 
epileptics showed a slowering of M C V of 
peroneal nerve <45 m/s, 21 a reduction of 
M C V of median nerve <50 m/s and 44 a 
reduction of SCV of median nerve <55 m/s 
(see Figures 1-3). Considering overlapping in 
some patients, 102 epileptics remained with at 
least 1 pathological value of NCV. Correlation 
with drug parameters were calculated sepa-
rately for males and females, because both 
sexes differed in dose of medication (Krause, 
1987). In both sexes, M C V of peroneal nerve 
and SCV of median nerve correlated negative 
with drug parameters, whereas only in males 
M C V of median nerve showed such a correla-
tion (Table 2). The results of the patients under 
monotherapy with phenytoin, carbamazepine, 
primidone, or valproate sodium since 1 year at 
least are compiled in Table 3. For all NCV's 
the group under carbamazepine showed the 
lowest values, this difference being significant 
for M C V of median nerve in Kruskal-Wallis 
test (/7<0.05) and after Duncan (for carbama-
zepine compared to phenytoin and valproate 
sodium). 
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Fig. 1. Frequency distribution of motor conduction 
velocity of median nerve in the forearm in epileptics ( I ) 
and controls (2). 
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Fig. 2. Frequency distribution of sensory conduction 
velocity of median nerve in the forearm in epileptics (1) 
and controls (2). 
100 
80 
60-
40-
20-
r r 
/ r 
40 45 50 55 60 m/s 
Fig. 3. Frequency distribution of motor conduction 
velocity of peroneal nerve in epileptics (1) and con-
trols (2). 
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Table 1. — Mean value and standard deviation of motor and 
sensory conduction velocity of median nerve and of motor 
conduction velocity of peroneal nerve in epileptics and 
controls with p value of Wilcoxon test 
Epilept: ics Controls 
P 
n X SD n X SD 
Median nerve, MCV 548 55.8 4.0 70 57.5 3.3 0.0002 
Median nerve, SCV 548 61.1 4.8 70 62.7 3.9 0.0014 
Peroneal nerve, MCV 548 49.3 3.9 70 51.9 4.0 0.0001 
Table 2. — Correlations between drug parameters (total 
amount of all anticonvulsants as equivalent units, average 
daily dose as equivalent units per day and duration of 
ant (epileptic treatment) and motor and sensory conduction 
velocity of median as well as motor conduction velocity of 
peroneal nerve (R = Spearman 'rank correlation coefficient 
and p value) in epileptic males (m, n = 313) and females (f 
n = 235) 
Sex Equivalent 
units total 
Equivalent 
units/d Duration 
Median nerve, m R= -0.13254 R= -0.13747 n.s. 
MCV /> = 0.0190 p = 0.0149 
f n.s. n.s. n.s. 
Median nerve, m R=-0.14491 R=-0.19165 n.s. 
SCV p = 0.0103 p = 0.0007 
f R=-0.17483 R= -0.13712 R= -0.15571 
p = 0.0072 p = 0.0357 /; = 0.0169 
Peroneal nerve, m R=-0.13731 R=-0.14558 n.s. 
MCV /? = 0.0151 y7 = 0.0099 
f R =-0.19850 R= -0.14275 R= - 0.19896 
p = 0.0022 p = 0.0287 p = 0.0022 
Table 3. — Mean value and standard deviation of motor and 
sensory conduction velocity of median nerve and motor 
conduction velocity of peroneal nerve in epileptics under 
monotherapy with phenytoin (PHT), primidone (PRM), 
carbamazepine (CBZ) or valproate sodium (VPA) 
PHT PRM 
n = 53 n = 81 
CBZ VPA 
n = 53 n = 32 
Median nerve, 
MCV 57.5±4.2 56.1 ±4 .2 54.9±4.3 56.7±3.9 
Median nerve, 
SCV 62.7±4.5 62.2±4.4 60.7±6.0 61.9±4.7 
Peroneal nerve, 
MCV 50.0±3.8 50.0±3.9 49.3±4.5 49.5±3.5 
Discussion 
The results of our study indicate, that long 
term therapy with antiepileptic drugs causes a 
lowering of NCV's. The influence of medication 
is confirmed by the negative correlations found 
between NCV's and mean daily dose a well as 
total amount of anticonvulsants taken by the 
epileptics. In accordance with the results of 
Geraldini et al. (12) and Taylor et al. (23) the 
males showed no correlations with duration of 
therapy, whereas the females of our study did 
so. The correlations between medication and 
M C V of peroneal nerve were more pronounced 
than those with NCV's of median nerve; so, the 
M C V of peroneal nerve seems to be the most 
sensitive in our study. The frequency of 19% of 
patients with at least one diminished NCV is in 
accordance with the incidence described by 
Lovelace and Horwitz (16) and Swift et al. (22). 
Swift et al. also found lowering of M C V of 
peroneal nerve as the most frequent sign of 
nerve involvement (22). As own investigations 
have shown, most cases with slowering of 
NCV's are only subclinical neuropathies with 
neither subjective complaints nor pathological 
reflex status (15). Concerning type of drugs, in 
former studies especially phenytoin has been 
thought to cause lowering of NCV's ("hydan-
toin neuropathy"); but patients with chronic 
intake of antiepileptic drugs mostly have a 
combination therapy with at least 2 drugs (20). 
The influence of the other anticonvulsants on 
NCV is not clear, regarding the literature: 
Results concerning the possible role of carba-
mazepine are controversial (3, 4, 17, 21, 22, 24, 
25); in patients under monotherapy with barbi-
turates an influence has been suggested, but 
only 6 patients were examined (21). Comparing 
the patients under monotherapy we found no 
significant differences in the M C V of peroneal 
nerve and SCV of median nerve; but M C V of 
median nerve was lower in the patients under 
carbamazepine compared to those under phe-
nytoin and valproate sodium. It is of interest, 
that Danner et al. in their prospective study 
also found lower NCV of median nerve under 
treatment with carbamazepine compared to 
phenytoin (3). A l l in all, the results of our study 
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suggest, that 1. under long term antiepileptic 
treatment mean NCV is lowered and that 2. 
phenytoin in long term therapy has no specific 
influence on NCV compared to other antiepi-
leptic drugs. This is also confirmed by the 
results of Geraldini et al. (12). Therefore we 
propose to change the term " hydantoin neuro-
pathy" into "anticonvulsant neuropathy" or 
"neuropathy induced by antiepileptic drugs". 
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